ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...

The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and ...

Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

People with lower kidney function may have higher levels of several blood markers often used in research on Alzheimer's disease and related dementias, according to a new systematic review and ...

Modest reductions in kidney function are associated with a heightened risk for adverse events, especially among younger adults, according to new research. In a retrospective, population-based cohort ...

Chronic kidney disease has been named the ninth leading cause of global death. Record numbers of men and women are currently estimated to have reduced kidney function, according to new research ...